Materials Healthcare Sector

Cambium Bio

Market Cap: AU$3.7m

A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.

Psyence Biomedical

Market Cap: US$2.3m

Engages in the development of botanical psilocybin-based psychedelic medicines.

Aspira Women's Health

Market Cap: US$2.3m

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

ALR Technologies SG

Market Cap: US$2.3m

A data management company, provides diabetes care management solutions for human and animal health diabetes.

Helius Medical Technologies

Market Cap: US$2.3m

A neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.

PHSC

Market Cap: UK£1.7m

Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.

Me Today

Market Cap: NZ$3.8m

Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.

TNF Pharmaceuticals

Market Cap: US$2.2m

A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

Medical Marijuana

Market Cap: US$2.2m

An investment holding company, operates in the cannabinoid-based nutraceutical industry.

Neural Therapeutics

Market Cap: CA$3.1m

A drug discovery company, focuses on plant-based active substances.

Vectus Biosystems

Market Cap: AU$3.5m

Engages in the medical research and development activities in Australia.

Accelerate Diagnostics

Market Cap: US$2.2m

An in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States and internationally.

Lifeline Biotechnologies

Market Cap: US$2.2m

Operates as a medical technology company in the United States.

CannaPharmaRX

Market Cap: US$2.2m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.

Affimed

Market Cap: US$2.1m

A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.

Aptevo Therapeutics

Market Cap: US$2.1m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

TALi Digital

Market Cap: AU$3.3m

A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia.

VG Life Sciences

Market Cap: US$2.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

Strainsforpains

Market Cap: US$2.1m

Operates as a medical marijuana data recommendation system.

JRSIS Health Care

Market Cap: US$2.1m

Develops and produces medical technology and equipment in the People’s Republic of China.

AXIM Biotechnologies

Market Cap: US$2.1m

Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.

Revitalist Lifestyle and Wellness

Market Cap: CA$2.8m

Operates medical clinics.

Omega Therapeutics

Market Cap: US$2.1m

Operates as a clinical-stage biotechnology company.

Xebra Brands

Market Cap: CA$2.9m

Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.

Traack Technologies

Market Cap: US$2.0m

Provides business and finance advisory services for small and medium sized companies.

Agentix

Market Cap: US$2.0m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

Ayala Pharmaceuticals

Market Cap: US$2.0m

A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.

Careteq

Market Cap: AU$3.1m

A medication management services company for health, aged, and home care sectors worldwide.

Radient Technologies

Market Cap: CA$2.7m

Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.

Universe Pharmaceuticals

Market Cap: US$1.9m

Through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China.

QHSLab

Market Cap: US$1.9m

A medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics.

DXS International

Market Cap: UK£1.4m

A healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa.

Syra Health

Market Cap: US$1.9m

A healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States.

Entero Therapeutics

Market Cap: US$1.9m

A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.

Aditxt

Market Cap: US$1.9m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.